Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis.

Jacob, S E; Berman, B; Nassiri, M; Vincek, V

Jacob, S E; Berman, B; Nassiri, M; Vincek, V.

Affiliation

Jacob SE; Department of Dermatology and Cutaneous Surgery, University of Miami, 1600 NW 10th Ave, Room 2023 A, Miami, FL 33138, USA.

Br J Dermatol ; 149 Suppl 66: 62-5, 2003 Nov.

Article in En | MEDLINE | ID: mdl-14616355

Subject(s)

Adjuvants, Immunologic/therapeutic use; Aminoquinolines/therapeutic use; Keloid/drug therapy; Administration, Topical; Apoptosis; Arabidopsis Proteins/genetics; Caspase 3; Caspase 6; Caspase 8; Caspases/genetics; Drug Administration Schedule; Fatty Acid Desaturases/genetics; Gene Expression/drug effects; Humans; Imiquimod; Keloid/pathology; Lymphotoxin-alpha/genetics

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Adjuvants, Immunologic / Aminoquinolines / Keloid Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Br J Dermatol Year: 2003 Document type: Article

Search on Google

XML

PubMed Links